Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | RARB | P10826 | 4/20 | 0.63 |
| ▸ | HTT | P42858 | 3/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5375208 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL26091696 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL4653588 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL4652780 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL430092 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL223467 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL5478282 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL9221792 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL9106297 | 0.98 | TP53 (0.72) | TP53TSHRPLA2G4BPKMRARB | |
| SCHEMBL14346716 | 0.95 | RARB (0.71) | TP53TSHRPLA2G4BPKMRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106978193-A | Flexure type liquid-crystal compounds and its synthetic method | 华东理工大学 | 2017-07-25 | — | — | CN | claimed |
| US-11252960-B2 | Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| US-11252960-B2 | Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| US-11224221-B2 | — | — | 2022-01-18 | — | — | US | disclosed |
| US-11224221-B2 | — | — | 2022-01-18 | — | — | US | disclosed |
| US-10351667-B2 | Method for producing polyester | RIKEN (JP) | 2019-07-16 | — | — | US | disclosed |
| US-20180086879-A1 | METHOD FOR PRODUCING POLYESTER | RIKEN (JP) | 2018-03-29 | — | — | US | disclosed |
| EP-3296342-A1 | METHOD FOR PRODUCING POLYESTER | Riken (JP) | 2018-03-21 | — | — | EP | disclosed |
| CN-106978193-A | Flexure type liquid-crystal compounds and its synthetic method | 华东理工大学 | 2017-07-25 | — | — | CN | disclosed |
| US-9364424-B2 | Topical cosmetic skin lightening compositions and methods of use thereof | STIEFEL LABORATORIES, INC. (US) | 2016-06-14 | — | — | US | disclosed |
| US-6423246-B1 | LIQUID CRYSTAL POLYMERS AND CROSSLINKING | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2002-07-23 | — | — | US | disclosed |
| EP-1046692-A1 | Thermostable pigments, films, effect coatings and mixtures for their preparation | Consortium für elektrochemische Industrie GmbH (DE) | 2000-10-25 | — | — | EP | disclosed |
| US-5833880-A | MIXTURE POLYMERIZABLE BY FREE RADICAL OR IONIC POLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-10 | — | — | US | disclosed |
| US-5424268-A | Imaging medium and process | POLAROID CORPORATION (US) | 1995-06-13 | — | — | US | disclosed |
| US-5414069-A | Main chain and side chains each with electroluminescent group and flexible spacer connecting group to main chain, polymer having at least two different electroluminescent groups, the groups not being conjugated with one another; preparations | POLAROID CORPORATION (US) | 1995-05-09 | — | — | US | disclosed |
| EP-0110495-B1 | COMPOSITE SUTURES OF SILK AND HYDROPHOBIC THERMOPLASTIC ELASTOMERS | ETHICON, INC. (US) | 1991-07-03 | — | — | EP | disclosed |
| US-4543952-A | POLYESTERS OF IMPROVED DIMENSIONAL STABILITY | ETHICON, INC. (US) | 1985-10-01 | — | — | US | disclosed |
| US-4461298-A | Composite sutures of silk and hydrophobic thermoplastic elastomers | ETHICON, INC. (US) | 1984-07-24 | — | — | US | disclosed |
| EP-0110495-A2 | Composite sutures of silk and hydrophobic thermoplastic elastomers | ETHICON, INC. (US) | 1984-06-13 | — | — | EP | disclosed |
| US-4433161-A | REACTING METHYL P-HYDROXYBENZOATE WITH ACETOXY-BROMO-OR CHLOROBUTANE UNDER ANHYDROUS CONDITIONS | ETHICON, INC. (US) | 1984-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11252960-B2 | Antibacterial composition including benzoic acid ester and methods of inhibiting bacterial growth utilizing the same | DBI, BCAT1, TBCA | TP53 4722/4885TSHR 4145/4885PLA2G4B 3660/4885 |
| US-11224221-B2 | — | TBCA, SPOUT1, BPGM | TP53 4638/4885TSHR 3974/4885PLA2G4B 3484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.